BARDNEWS: Ultrasound Imaging and Chemo Brain

IMAGING SCIENCE NEWS

How Sound Waves Can Help Measure, Screen and Assess Cognitive Changes in "Chemo Brain" Sufferers

“Chemo brain” — clinically described as cancer-related cognitive impairment (CRCI) — is not a single structural lesion that shows up clearly on one scan. It is a functional and microvascular condition involving inflammation, blood flow changes, white matter disruption, and altered neural connectivity. While MRI and PET imaging are often discussed in research settings, ultrasound offers a powerful, accessible, and dynamic way to evaluate many of the neurological changes associated with cognitive decline — directly and indirectly.

Ultrasound does not “see thoughts,” but it can measure the biological systems that support cognition: blood flow, vascular integrity, nerve structure, and inflammatory response.

1. Transcranial Doppler (TCD): Measuring Cerebral Blood Flow

Transcranial Doppler ultrasound evaluates blood flow velocity in the brain’s major arteries. Cognitive clarity depends on stable cerebral perfusion. Chemotherapy-related inflammation and endothelial dysfunction may alter blood flow dynamics.

TCD can assess:

· Middle cerebral artery flow velocity

· Pulsatility index (vascular resistance)

· Microembolic signals

· Cerebrovascular reactivity

If chemotherapy affects vascular elasticity or causes subtle microvascular injury, TCD may reveal abnormal resistance patterns. Reduced flow adaptability during cognitive stress testing may correlate with attention or processing deficits.

2. Carotid and Vertebral Artery Ultrasound

The brain relies on carotid and vertebral arteries for oxygenated blood supply. Chemotherapy can contribute to endothelial dysfunction and accelerated vascular aging. Carotid Doppler ultrasound evaluates:

· Intima-media thickness (IMT)

· Plaque formation

· Flow turbulence

· Arterial stiffness

Increased vascular stiffness or early plaque formation can compromise cerebral perfusion, contributing to fatigue and slowed cognition.

3. Retinal Artery Ultrasound: A Window to Brain Microcirculation

The retinal artery reflects cerebral microvascular health. Since the retina is neurologically derived tissue, changes in retinal blood flow may parallel changes in brain perfusion. Ultrasound assessment of the retinal artery can:

· Measure microvascular flow velocity

· Detect vascular resistance changes

· Indicate systemic endothelial dysfunction

Subtle microvascular compromise may contribute to cognitive fog, especially in patients experiencing systemic inflammation after chemotherapy.

4. Functional Ultrasound (fUS): Emerging Brain Activity Mapping

Although still evolving, functional ultrasound imaging can detect real-time changes in cerebral blood volume related to neural activity. This technology, used in research settings, may one day allow clinicians to visualize activation patterns during cognitive tasks. Functional ultrasound may help identify:

· Reduced frontal lobe activation

· Impaired hippocampal perfusion

· Altered task-related hemodynamic response

Such findings could correlate directly with executive dysfunction and memory impairment.

5. Vagus Nerve Ultrasound

Chemotherapy-related inflammation affects the autonomic nervous system. The vagus nerve plays a central role in regulating inflammation and cognitive clarity. Ultrasound of the vagus nerve can assess:

· Nerve diameter

· Structural integrity

· Signs of inflammatory swelling

Autonomic imbalance contributes to fatigue, poor focus, and brain fog. Evaluating vagal structure provides insight into systemic inflammatory burden.

6. Peripheral Nerve Ultrasound

While commonly used for neuropathy, peripheral nerve ultrasound indirectly informs cognitive health. Severe chemotherapy-induced neuropathy may reflect widespread neurotoxicity.

Assessment includes:

· Nerve cross-sectional area

· Myelin integrity

· Fascicular pattern changes

Systemic neurotoxicity may affect both peripheral and central nervous systems.

7. Cerebral Venous Flow Assessment

Venous outflow affects intracranial pressure and brain oxygenation. Ultrasound of jugular veins evaluates venous drainage efficiency. Impaired drainage may contribute to:

· Head pressure

· Cognitive slowing

· Fatigue

Optimizing cerebral hemodynamics supports mental clarity.

8. Cardiac Echocardiography: Indirect Cognitive Assessment

Some chemotherapy agents affect cardiac function. Reduced cardiac output diminishes cerebral perfusion.

Echocardiography can measure:

· Ejection fraction

· Stroke volume

· Cardiac strain

If cardiac performance declines, cognitive symptoms may follow due to reduced oxygen delivery to the brain.

9. Monitoring Inflammation Through Vascular Reactivity

Ultrasound can measure flow-mediated dilation (FMD) in peripheral arteries. This reflects endothelial health. Chemotherapy-induced oxidative stress impairs vascular reactivity. Poor endothelial function correlates with cognitive fatigue and slowed processing.

The Bigger Picture

Ultrasound cannot replace neuropsychological testing. It does not directly diagnose chemo brain in isolation. However, it measures the biological terrain underlying cognitive performance:

· Blood flow

· Microvascular health

· Nerve structure

· Inflammatory impact

· Cardiac contribution

Because ultrasound is non-invasive, repeatable, radiation-free, and dynamic, it offers a valuable tool for baseline comparison and longitudinal monitoring. Chemo brain is not merely “in the mind.” It often reflects measurable physiological changes. Ultrasound allows clinicians to assess these changes safely and in real time—bringing objectivity to a condition patients too often struggle to validate. When cognition changes, the first step is understanding the biology behind it. Sound waves may help illuminate the path.

Friday, February 27, 2026

Ultrasound Imaging and Chemo Brain